Zogenix is seeking an approval of Zohydro for the treatment of chronic pain in opioid‐experienced patients. After an initial read of the documents, we note that within the FDA materials, the agency ...
The indication from WellPoint, one of the largest insurance companies in the world, that cell-free fetal DNA-based screening for fetal aneuploidy is d...
Guidance currently calls for $0.33 to $0.38 for the fourth quarter and $1.83 to $1.88 for the full year. The revised 2012 guidance reflects the recent...
In fairness, the company incurred several facility relocation costs all at once (one-time items) as well as some expenses related to disruption caused...
The transaction is expected to add $75 million in revenue (7% of 2013 base) and be neutral to slightly accretive to EPS including integration costs in...
